Manufacturer record
Sano-Cito Therapeutics Inc: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by Sano-Cito Therapeutics Inc (Himachal Pradesh) were declared Not of Standard Quality between July 2022 and June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
4 records linked to Sano-Cito Therapeutics Inc in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Levosalbutamol Sulphate, Ambroxol HCl & Guaiphenesin Syrup 60 ml | SD-1376CMfg 2025-07 · Exp 2027-06 | The sample does not conform to claim as per Schedule V of Drugs and Cosmetic Acts and Rules 1945 with respect to Assay/content of Levosalbutamol sulphate Equivalent to Levosalbutamol.Assay | CDL KolkataCDSCO lab | Jun 2026 |
| Ramipril Tablets IP | SD-1457Mfg 2025-07 · Exp 2027-06 | The sample does not conform to the IP with respect to Assay and DissolutionAssay | DTL, JaipurState lab | Nov 2025 |
| Ofloxacin & Ornidazole Tablets IP (Zeof-O) | SCZAG230 07Mfg 2023-06 · Exp 2025-11 | DissolutionDissolution | CDL KolkataCDSCO lab | Jan 2025 |
| Ofloxacin & Ornidazole Tablets IP | SCZAG21004Mfg 2021-06 · Exp 2023-11 | DissolutionDissolution | RDTL GuwahatiState lab | Jul 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.